The chemical substance known as "(6R,7R)-3-[4-(Carbamoylmethyl)thiazol-2-ylsulfanyl]-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid," with the CAS number 194928-82-0, is a cephalosporin antibiotic. This compound features a cephem core structure, which is characteristic of cephalosporins, and is known for its broad-spectrum antibacterial activity. The presence of a thiazole ring and a carbamoylmethyl group contributes to its unique pharmacological properties, enhancing its efficacy against various bacterial strains. The compound also contains an amido group, which can influence its solubility and stability. Its carboxylic acid functionality is crucial for its interaction with bacterial enzymes, facilitating its mechanism of action. Overall, this substance is of interest in medicinal chemistry for its potential therapeutic applications, particularly in treating infections caused by resistant bacteria. As with many antibiotics, understanding its structure-activity relationship is essential for optimizing its use and minimizing resistance development.

(6R,7R)-3-[4-(Carbamoylmethyl)thiazol-2-ylsulfanyl]-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid

194928-82-0: The chemical substance known as "(6R,7R)-3-[4-(Carbamoylmethyl)thiazol-2-ylsulfanyl]-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid," with the CAS number 194928-82-0, is a cephalosporin antibiotic. This compound features a cephem core structure, which is characteristic of cephalosporins, and is known for its broad-spectrum antibacterial activity. The presence of a thiazole ring and a carbamoylmethyl group contributes to its unique pharmacological properties, enhancing its efficacy against various bacterial strains. The compound also contains an amido group, which can influence its solubility and stability. Its carboxylic acid functionality is crucial for its interaction with bacterial enzymes, facilitating its mechanism of action. Overall, this substance is of interest in medicinal chemistry for its potential therapeutic applications, particularly in treating infections caused by resistant bacteria. As with many antibiotics, understanding its structure-activity relationship is essential for optimizing its use and minimizing resistance development.

FR-193879 is an efficacious cephem derivative, it has extremely potent therapeutic efficacy against H. pylori.

CAS 194928-82-0

(6R,7R)-3-[4-(Carbamoylmethyl)thiazol-2-ylsulfanyl]-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid

FR-193879

Ref: TM-T27378